Pituitary Dwarfism
📧 Sign up to get email alerts when something new happens for Pituitary Dwarfism.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-08-05EMA Authorised: Omnitrope (somatropin) — Sandoz GmbH
The European Medicines Agency authorised Omnitrope (somatropin) by Sandoz GmbH for the treatment of Turner syndrome, Prader-Willi syndrome, …
-
EMA approval · 2023-07-20EMA Authorised: NutropinAq (somatropin) — Ipsen Pharma
EMA authorised NutropinAq (somatropin) for Turner syndrome and pituitary dwarfism, with Ipsen Pharma as MAH.
-
CLINICAL_TRIALS research · 2017-04-12Clinical Trial Update: An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
An observational registry assessing real-world outcomes and safety of Norditropin (somatropin) in children and adults treated for growth hor…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children [Phase 3]
Phase 3 trial of somatropin (Norditropin) in insulin-like growth factor (IGF) deficient children has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children [Phase 4]
This document reports a Phase IV clinical trial evaluating pegylated somatropin for growth hormone deficiency in children. The current statu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Pharmacodynamics of CNP During Growth Hormone Treatment
An update on the pharmacodynamic effects of C-type natriuretic peptide during growth hormone treatment in children with pituitary dwarfism o…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Drug Use Investigation of Somatropin for GHD-ADULTS.
Completed clinical trial investigating somatropin use in adults with growth hormone deficiency; Pfizer posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
A completed clinical trial evaluated bone mineral density in adolescents with growth hormone deficiency due to pituitary dwarfism or Turner …
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency [Phase 3]
Phase 3 adolescent transition study evaluating Saizen for childhood-onset growth hormone deficiency has completed with results posted.
-
EMA withdrawal · 2007-03-26EMA Application withdrawn: Iplex (mecasermin rinfabate) — Insmed Europe Ltd
The EMA application for Iplex (mecasermin rinfabate) by Insmed Europe Ltd has been withdrawn.